December 28, 2011 /

Biglycan (December 2011)

by: Parent Project Muscular Dystrophy

Biglycan (December 2011)

Biglycan as a protein therapeutic for Duchenne Muscular Dystrophy Justin R. Fallon, Department of Neuroscience, Brown University

15 years ago

Research & Clinical Trial Webinars,

You may also like

Town Hall: Deramiocel FDA Advisory Committee Meeting Update

Town Hall: Deramiocel FDA Advisory Committee Meeting Update

2 weeks ago

Livestream with the PAAC: A Day in the Life

Livestream with the PAAC: A Day in the Life

2 weeks ago

PPMD Adult Advisory Committee (PAAC) Webinars,

Livestream with the PAAC: DIY Life Hacks

Livestream with the PAAC: DIY Life Hacks

2 weeks ago

PPMD Adult Advisory Committee (PAAC) Webinars,

Webinar: Your Voice Matters - Preparing for the FDA Advisory Committee Meeting on Deramiocel

Webinar: Your Voice Matters – Preparing for the FDA Advisory Committee Meeting on Deramiocel

1 month ago

Livestream with the PAAC: I Get Around

Livestream with the PAAC: I Get Around

3 months ago

PPMD Adult Advisory Committee (PAAC) Webinars,

Webinar: Exercise and Dystrophinopathy - What Families Need to Know

Webinar: Exercise and Dystrophinopathy – What Families Need to Know

3 months ago

physical therapy

Webinar: Ataluren and the Current Regulatory Landscape

Webinar: Ataluren and the Current Regulatory Landscape

4 months ago

ptc therapeutics

Webinar: Understanding the Expanded Duchenne Natural History Study (eDNHS)

Webinar: Understanding the Expanded Duchenne Natural History Study (eDNHS)

4 months ago

12 3…29 »

Page 1 of 29

Join Our Mailing List